Last 12 months
Inside the activity.
2 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 1 | 1 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 1 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 09, 2023 Filed Feb 13, 2023 22:07 UTC |
Paggiarino Dario A.Chief Medical Officer
|
Exercise / conversionCommon Stock | 5,833 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-001337 · primarydocument.xml · nonDerivative · entry 2 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,451 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 22:07 UTC |
Paggiarino Dario A.Chief Medical Officer
|
Exercise / conversionCommon Stock | 4,967 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-001337 · primarydocument.xml · nonDerivative · entry 1 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,618 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 22:03 UTC |
Duker Jay S.President and COO
|
Exercise / conversionRestricted Stock Units · Derivative | 4,967 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-001333 · primarydocument.xml · derivative · entry 6 Duker Jay S. · CIK 0001630864 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,967 Underlying: Common Stock · 4,967 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The restricted stock units vests in three ratable annual installments beginning February 9, 2022. F3 · derivative.expiration_date: The restricted stock units vests in three ratable annual installments beginning February 9, 2022. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 22:03 UTC |
Duker Jay S.President and COO
|
Exercise / conversionRestricted Stock Units · Derivative | 7,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-001333 · primarydocument.xml · derivative · entry 5 Duker Jay S. · CIK 0001630864 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 7,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock units vests in three annual installments beginning February 9, 2023. F2 · derivative.expiration_date: The restricted stock units vests in three annual installments beginning February 9, 2023. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 22:03 UTC |
Duker Jay S.President and COO
|
Tax withholdingCommon Stock | 1,722 | $4.17 | $7,180.74 |
DisclosureSEC source: 0001562180-23-001333 · primarydocument.xml · nonDerivative · entry 4 Duker Jay S. · CIK 0001630864 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,221 F1 · price: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of their withholding right following the vesting of the restricted stock units. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 22:03 UTC |
Duker Jay S.President and COO
|
Tax withholdingCommon Stock | 2,426 | $4.17 | $10,116.42 |
DisclosureSEC source: 0001562180-23-001333 · primarydocument.xml · nonDerivative · entry 3 Duker Jay S. · CIK 0001630864 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,943 F1 · price: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of their withholding right following the vesting of the restricted stock units. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 22:03 UTC |
Duker Jay S.President and COO
|
Exercise / conversionCommon Stock | 4,967 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-001333 · primarydocument.xml · nonDerivative · entry 2 Duker Jay S. · CIK 0001630864 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,369 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 22:03 UTC |
Duker Jay S.President and COO
|
Exercise / conversionCommon Stock | 7,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-001333 · primarydocument.xml · nonDerivative · entry 1 Duker Jay S. · CIK 0001630864 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,402 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 06, 2023 Filed Jan 10, 2023 17:52 UTC |
Jones David ScottSVP & Chief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 91,655 | $0.00 Strike: $3.26 | $0.00 |
DisclosureSEC source: 0001562180-23-000344 · primarydocument.xml · derivative · entry 1 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,655 Underlying: Common Stock · 91,655 shares Expires 2033-01-05 F1 · derivative.exercise_date: The option to purchase will vest and become exercisable as follows: 25% at January 6th, 2024 and the remainder ratably, on a monthly basis, over the remaining three years. Read SEC document |
| January 06, 2023 Filed Jan 10, 2023 22:58 UTC |
Lurker NancyDirector · CEO
|
GrantStock Option (Right to Buy) · Derivative | 450,800 | $0.00 Strike: $3.26 | $0.00 |
DisclosureSEC source: 0001562180-23-000347 · primarydocument.xml · derivative · entry 1 Lurker Nancy · CIK 0001450485 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450,800 Underlying: Common Stock · 450,800 shares Expires 2033-01-05 F1 · derivative.exercise_date: The option to purchase will vest and become exercisable as follows: 25% at January 6th, 2024 and the remainder ratably, on a monthly basis, over the remaining three years. Read SEC document |
| January 06, 2023 Filed Jan 10, 2023 22:53 UTC |
Elston GeorgeChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 91,655 | $0.00 Strike: $3.26 | $0.00 |
DisclosureSEC source: 0001562180-23-000345 · primarydocument.xml · derivative · entry 1 Elston George · CIK 0001429932 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,655 Underlying: Common Stock · 91,655 shares Expires 2033-01-05 F1 · derivative.exercise_date: The option to purchase will vest and become exercisable as follows: 25% at January 6th, 2024 and the remainder ratably, on a monthly basis, over the remaining three years. Read SEC document |
| January 06, 2023 Filed Jan 10, 2023 22:56 UTC |
Duker Jay S.President and COO
|
GrantStock Option (Right to Buy) · Derivative | 124,755 | $0.00 Strike: $3.26 | $0.00 |
DisclosureSEC source: 0001562180-23-000346 · primarydocument.xml · derivative · entry 1 Duker Jay S. · CIK 0001630864 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,755 Underlying: Common Stock · 124,755 shares Expires 2033-01-05 F1 · derivative.exercise_date: The option to purchase will vest and become exercisable as follows: 25% at January 6th, 2024 and the remainder ratably, on a monthly basis, over the remaining three years. Read SEC document |
| January 06, 2023 Filed Jan 10, 2023 22:51 UTC |
Pine Michael CraigChief Corp Dev.&Strat. Officer
|
GrantStock Option (Right to Buy) · Derivative | 91,655 | $0.00 Strike: $3.26 | $0.00 |
DisclosureSEC source: 0001562180-23-000343 · primarydocument.xml · derivative · entry 1 Pine Michael Craig · CIK 0001904458 · Chief Corp Dev.&Strat. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,655 Underlying: Common Stock · 91,655 shares Expires 2033-01-05 F1 · derivative.exercise_date: The option to purchase will vest and become exercisable as follows: 25% at January 6th, 2024 and the remainder ratably, on a monthly basis, over the remaining three years. Read SEC document |
| January 06, 2023 Filed Jan 10, 2023 22:50 UTC |
Paggiarino Dario A.Chief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 91,655 | $0.00 Strike: $3.26 | $0.00 |
DisclosureSEC source: 0001562180-23-000342 · primarydocument.xml · derivative · entry 1 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,655 Underlying: Common Stock · 91,655 shares Expires 2033-01-05 F1 · derivative.exercise_date: The option to purchase will vest and become exercisable as follows: 25% at January 6th, 2024 and the remainder ratably, on a monthly basis, over the remaining three years. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 12:38 UTC |
Duker Jay S.Chief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 15,258 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-007459 · primarydocument.xml · derivative · entry 3 Duker Jay S. · CIK 0001630864 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,258 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested on the one-year anniversary of the grant date. F2 · derivative.expiration_date: Fully vested on the one-year anniversary of the grant date. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 12:38 UTC |
Duker Jay S.Chief Operating Officer
|
Tax withholdingCommon Stock | 4,479 | $5.42 | $24,276.18 |
DisclosureSEC source: 0001562180-22-007459 · primarydocument.xml · nonDerivative · entry 2 Duker Jay S. · CIK 0001630864 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,402 F1 · price: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 12:38 UTC |
Duker Jay S.Chief Operating Officer
|
Exercise / conversionCommon Stock | 15,258 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-007459 · primarydocument.xml · nonDerivative · entry 1 Duker Jay S. · CIK 0001630864 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,881 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 07, 2022 Filed Sep 9, 2022 20:19 UTC |
Duker Jay S.Chief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 65,300 | $0.00 Strike: $9.45 | $0.00 |
DisclosureSEC source: 0001562180-22-006581 · primarydocument.xml · derivative · entry 1 Duker Jay S. · CIK 0001630864 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,300 Underlying: Common Stock · 65,300 shares Expires 2032-09-06 F1 · derivative.exercise_date: The option to purchase will vest and become exercisable over a three year period as follows: 50% at the one year anniversary of grant and then ratably over the remaining twenty-four months Read SEC document |
| July 11, 2022 Filed Jul 13, 2022 20:47 UTC |
Zaderej Karen L.Director
|
GrantStock Option (Right to Buy) · Derivative | 22,000 | $0.00 Strike: $8.22 | $0.00 |
DisclosureSEC source: 0001562180-22-005662 · primarydocument.xml · derivative · entry 2 Zaderej Karen L. · CIK 0001530968 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,000 Underlying: Common Stock · 22,000 shares Expires 2032-07-10 F2 · derivative.exercise_date: The option becomes exercisable in three ratable annual installments beginning on July 11, 2023. Read SEC document |
| July 11, 2022 Filed Jul 13, 2022 20:47 UTC |
Zaderej Karen L.Director
|
GrantRestricted Stock Units · Derivative | 6,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-005662 · primarydocument.xml · derivative · entry 1 Zaderej Karen L. · CIK 0001530968 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires not disclosed F1 · derivative.exercise_date: The restricted stock units will vest in three equal annual installments beginning July 11, 2023. F1 · derivative.expiration_date: The restricted stock units will vest in three equal annual installments beginning July 11, 2023. Read SEC document |
| June 23, 2022 Filed Jun 27, 2022 20:38 UTC |
ADAMIS ANTHONY PDirector
|
GrantStock Option (Right to Buy) · Derivative | 22,000 | $0.00 Strike: $7.54 | $0.00 |
DisclosureSEC source: 0001562180-22-005368 · primarydocument.xml · derivative · entry 2 ADAMIS ANTHONY P · CIK 0001277479 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,000 Underlying: Common Stock · 22,000 shares Expires 2032-06-23 F2 · derivative.exercise_date: The option becomes exercisable in three ratable annual installments beginning on June 23, 2023. Read SEC document |
| June 23, 2022 Filed Jun 27, 2022 20:38 UTC |
ADAMIS ANTHONY PDirector
|
GrantRestricted Stock Units · Derivative | 6,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-005368 · primarydocument.xml · derivative · entry 1 ADAMIS ANTHONY P · CIK 0001277479 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires not disclosed F1 · derivative.exercise_date: The restricted stock units will vest in three equal annual installments beginning June 23, 2023. F1 · derivative.expiration_date: The restricted stock units will vest in three equal annual installments beginning June 23, 2023. Read SEC document |
| March 14, 2022 Filed Mar 15, 2022 20:21 UTC |
Pine Michael CraigChief Corp Dev.&Strat. Officer
|
PurchaseCommon Stock | 1,000 | $12.21 | $12,210.00 |
DisclosureSEC source: 0001562180-22-002643 · primarydocument.xml · nonDerivative · entry 1 Pine Michael Craig · CIK 0001904458 · Chief Corp Dev.&Strat. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 18:22 UTC |
Jones David ScottSVP & Chief Commercial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 4,105 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-002137 · primarydocument.xml · derivative · entry 3 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,105 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock units vested in three equal installments on the following dates: 6.30.2020, 2.28.2021 and 2.28.2022. F2 · derivative.expiration_date: The restricted stock units vested in three equal installments on the following dates: 6.30.2020, 2.28.2021 and 2.28.2022. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 18:22 UTC |
Jones David ScottSVP & Chief Commercial Officer
|
Tax withholdingCommon Stock | 1,130 | $9.95 | $11,243.50 |
DisclosureSEC source: 0001562180-22-002137 · primarydocument.xml · nonDerivative · entry 2 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,599 F1 · price: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 18:22 UTC |
Jones David ScottSVP & Chief Commercial Officer
|
Exercise / conversionCommon Stock | 4,105 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-002137 · primarydocument.xml · nonDerivative · entry 1 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,729 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 23:21 UTC |
Lurker NancyDirector · President & CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 12,466 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-002135 · primarydocument.xml · derivative · entry 2 Lurker Nancy · CIK 0001450485 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,466 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock units vested in three equal installments on the following dates: 6.30.2020, 2.28.2021 and 2.28.2022. F1 · derivative.expiration_date: The restricted stock units vested in three equal installments on the following dates: 6.30.2020, 2.28.2021 and 2.28.2022. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 23:21 UTC |
Lurker NancyDirector · President & CEO
|
Exercise / conversionCommon Stock | 12,466 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-002135 · primarydocument.xml · nonDerivative · entry 1 Lurker Nancy · CIK 0001450485 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,281 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 23:21 UTC |
Paggiarino Dario A.Chief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 4,105 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-002136 · primarydocument.xml · derivative · entry 3 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,105 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock units vested in three equal installments on the following dates: 6.30.2020, 2.28.2021 and 2.28.2022. F2 · derivative.expiration_date: The restricted stock units vested in three equal installments on the following dates: 6.30.2020, 2.28.2021 and 2.28.2022. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 23:21 UTC |
Paggiarino Dario A.Chief Medical Officer
|
Tax withholdingCommon Stock | 1,294 | $9.95 | $12,875.30 |
DisclosureSEC source: 0001562180-22-002136 · primarydocument.xml · nonDerivative · entry 2 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,651 F1 · price: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 23:21 UTC |
Paggiarino Dario A.Chief Medical Officer
|
Exercise / conversionCommon Stock | 4,105 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-002136 · primarydocument.xml · nonDerivative · entry 1 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,945 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2022 Filed Feb 23, 2022 21:13 UTC |
Lurker NancyDirector · President & CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 13,717 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001757 · primarydocument.xml · derivative · entry 2 Lurker Nancy · CIK 0001450485 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,718 Underlying: Common Stock · 13,717 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock units vest in three ratable annual installments beginning February 21, 2020. F1 · derivative.expiration_date: The restricted stock units vest in three ratable annual installments beginning February 21, 2020. Read SEC document |
| February 21, 2022 Filed Feb 23, 2022 21:13 UTC |
Lurker NancyDirector · President & CEO
|
Exercise / conversionCommon Stock | 13,717 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001757 · primarydocument.xml · nonDerivative · entry 1 Lurker Nancy · CIK 0001450485 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,815 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 16:48 UTC |
ANDO GORANDirector
|
GrantStock Option (Right to Buy) · Derivative | 12,000 | $0.00 Strike: $10.13 | $0.00 |
DisclosureSEC source: 0001562180-22-001417 · primarydocument.xml · derivative · entry 4 ANDO GORAN · CIK 0001110748 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2032-02-09 Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 16:48 UTC |
ANDO GORANDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 2,750 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001417 · primarydocument.xml · derivative · entry 3 ANDO GORAN · CIK 0001110748 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested on the one-year anniversary of the grant date. F2 · derivative.expiration_date: Fully vested on the one-year anniversary of the grant date. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 16:48 UTC |
ANDO GORANDirector
|
GrantRestricted Stock Units · Derivative | 3,250 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001417 · primarydocument.xml · derivative · entry 2 ANDO GORAN · CIK 0001110748 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,250 Underlying: Common Stock · 3,250 shares Expires not disclosed F1 · derivative.exercise_date: Will fully vest on the one-year anniversary of the grant date. F1 · derivative.expiration_date: Will fully vest on the one-year anniversary of the grant date. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 16:48 UTC |
ANDO GORANDirector
|
Exercise / conversionCommon Stock | 2,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001417 · primarydocument.xml · nonDerivative · entry 1 ANDO GORAN · CIK 0001110748 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 16:39 UTC |
Jones David ScottSVP & Chief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $10.13 | $0.00 |
DisclosureSEC source: 0001562180-22-001412 · primarydocument.xml · derivative · entry 5 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2032-02-09 F5 · derivative.exercise_date: The option to purchase will vest and become exercisable as follows: 25% at February 9th, 2023 and the remainder ratably, on a monthly basis, over the remaining three years. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 16:39 UTC |
Jones David ScottSVP & Chief Commercial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 4,966 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001412 · primarydocument.xml · derivative · entry 4 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,934 Underlying: Common Stock · 4,966 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The restricted stock units vest in three ratable annual installments beginning February 9, 2022. F4 · derivative.expiration_date: The restricted stock units vest in three ratable annual installments beginning February 9, 2022. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 16:39 UTC |
Jones David ScottSVP & Chief Commercial Officer
|
GrantRestricted Stock Units · Derivative | 15,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001412 · primarydocument.xml · derivative · entry 3 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires not disclosed F3 · derivative.exercise_date: The restricted stock units will vest in three ratable annual installments beginning February 9, 2023. F3 · derivative.expiration_date: The restricted stock units will vest in three ratable annual installments beginning February 9, 2023. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 16:39 UTC |
Jones David ScottSVP & Chief Commercial Officer
|
Tax withholdingCommon Stock | 1,473 | $10.13 | $14,921.49 |
DisclosureSEC source: 0001562180-22-001412 · primarydocument.xml · nonDerivative · entry 2 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,624 F2 · price: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 16:39 UTC |
Jones David ScottSVP & Chief Commercial Officer
|
Exercise / conversionCommon Stock | 4,966 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001412 · primarydocument.xml · nonDerivative · entry 1 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,097 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 886 shares acquired on July 30, 2021 and 865 shares acquired on January 31,2022 pursuant to EyePoint's 2019 Employee Stock Purchase Plan. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 16:54 UTC |
Landis John B.Director
|
GrantStock Option (Right to Buy) · Derivative | 11,000 | $0.00 Strike: $10.13 | $0.00 |
DisclosureSEC source: 0001562180-22-001420 · primarydocument.xml · derivative · entry 4 Landis John B. · CIK 0001477283 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Common Stock · 11,000 shares Expires 2032-02-09 Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 16:54 UTC |
Landis John B.Director
|
GrantRestricted Stock Units · Derivative | 3,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001420 · primarydocument.xml · derivative · entry 3 Landis John B. · CIK 0001477283 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires not disclosed F2 · derivative.exercise_date: Will fully vest on the one-year anniversary of the grant date. F2 · derivative.expiration_date: Will fully vest on the one-year anniversary of the grant date. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 16:54 UTC |
Landis John B.Director
|
Exercise / conversionRestricted Stock Units · Derivative | 2,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001420 · primarydocument.xml · derivative · entry 2 Landis John B. · CIK 0001477283 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested on the one-year anniversary of the grant date. F1 · derivative.expiration_date: Fully vested on the one-year anniversary of the grant date. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 16:54 UTC |
Landis John B.Director
|
Exercise / conversionCommon Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001420 · primarydocument.xml · nonDerivative · entry 1 Landis John B. · CIK 0001477283 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 21:38 UTC |
Lurker NancyDirector · President & CEO
|
GrantStock Option (Right to Buy) · Derivative | 240,000 | $0.00 Strike: $10.13 | $0.00 |
DisclosureSEC source: 0001562180-22-001410 · primarydocument.xml · derivative · entry 4 Lurker Nancy · CIK 0001450485 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,000 Underlying: Common Stock · 240,000 shares Expires 2032-02-09 F4 · derivative.exercise_date: The option to purchase will vest and become exercisable as follows: 25% at February 9th, 2023 and the remainder ratably, on a monthly basis, over the remaining three years. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 21:38 UTC |
Lurker NancyDirector · President & CEO
|
GrantRestricted Stock Units · Derivative | 60,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001410 · primarydocument.xml · derivative · entry 3 Lurker Nancy · CIK 0001450485 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires not disclosed F3 · derivative.exercise_date: These restricted stock units will vest in three ratable annual installments beginning February 9, 2023. F3 · derivative.expiration_date: These restricted stock units will vest in three ratable annual installments beginning February 9, 2023. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 21:38 UTC |
Lurker NancyDirector · President & CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 17,533 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001410 · primarydocument.xml · derivative · entry 2 Lurker Nancy · CIK 0001450485 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,067 Underlying: Common Stock · 17,533 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock units vest in three ratable annual installments beginning February 9, 2022. F2 · derivative.expiration_date: The restricted stock units vest in three ratable annual installments beginning February 9, 2022. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 21:38 UTC |
Lurker NancyDirector · President & CEO
|
Exercise / conversionCommon Stock | 17,533 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001410 · primarydocument.xml · nonDerivative · entry 1 Lurker Nancy · CIK 0001450485 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,098 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 3,019 shares acquired on January 31, 2022 pursuant to EyePoint's 2019 Employee Stock Purchase Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.